Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Summary of Significant Accounting Policies - Schedule of Computation of Diluted Shares Outstanding (Details) - shares	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Schedule of Computation of Diluted Shares Outstanding [Line Items]
Total anti-dilutive	2,730,180	49,578	49,578
Warrants [Member]
Schedule of Computation of Diluted Shares Outstanding [Line Items]
Total anti-dilutive	2,666,096	11,245	11,245
Stock options [Member]
Schedule of Computation of Diluted Shares Outstanding [Line Items]
Total anti-dilutive	64,084	38,333	38,333